The Cost-Effectiveness of Cyclooxygenase-2 Selective Inhibitors in the Management of Chronic Arthritis

Figure 2. The summary estimate is the relative risk ( ). CLASS = Celecoxib Long-term Arthritis Safety Study; SUCCESS = Successive Celecoxib Efficacy and Safety Study.
Figure 2. The summary estimate is the relative risk ( ). CLASS = Celecoxib Long-term Arthritis Safety Study; SUCCESS = Successive Celecoxib Efficacy and Safety Study. Meta-analysis using the fixed-effects model of randomized, controlled trials that report upper gastrointestinal dyspeptic symptoms in patients receiving a coxib versus a nonselective nonsteroidal anti-inflammatory drug.RR

This Article

  1. Ann Intern Med May 20, 2003 vol. 138 no. 10 795-806
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues